ICH GCP R3 is now in English & EU languages. Book Now

About

The Pharmacovigilance (PV) Learning Path is a comprehensive, structured program designed to build end-to-end expertise in drug and medical device safety in alignment with global regulatory expectations. This learning path covers the complete pharmacovigilance lifecycle—from adverse event collection and case processing to signal detection, risk assessment, audits, and regulatory compliance across multiple regions.

Learners will gain a strong understanding of international PV regulations, safety documentation, inspection readiness, and post-marketing surveillance requirements. The curriculum is designed to bridge theory with real-world application, ensuring learners are prepared to support pharmacovigilance operations in pharmaceutical, biotechnology, and medical device organizations.

This learning path is suitable for beginners entering pharmacovigilance, as well as professionals in clinical research, regulatory affairs, quality, and safety roles who want to strengthen or expand their PV capabilities. Upon completion, learners will be equipped to contribute effectively to patient safety, regulatory submissions, audits, and global safety systems.

Courses Included

Module 1 – Drug Safety

Covers core pharmacovigilance concepts including adverse event reporting, case processing, safety documentation, and the role of PV in patient protection

duration4 hoursCPD points4 points
More Info
Module 2 – Global Regulatory Requirements

Provides an in-depth overview of global PV regulatory frameworks, including ICH guidelines, FDA, EMA, and international reporting requirements

duration3 hoursCPD points3 points
More Info
Module 3 – PV Audit

Focuses on PV system audits, inspection preparedness, common findings, CAPA management, and regulatory authority expectations

duration3 hoursCPD points3 points
More Info
Module 4 – Signalling & Risk Assessment

Teaches methodologies for identifying safety signals, evaluating benefit–risk profiles, and managing emerging safety concerns throughout the product lifecycle

duration3 hoursCPD points4 points
More Info
Device Safety and Vigilance

Covers medical device vigilance requirements, post-market surveillance, adverse event reporting, and global regulatory obligations under device regulations

duration4 hoursCPD points4 points
More Info

Our Certified Customers

novartis
NHS
takeda
roche
baxter

Learner Rating & Reviews

4.7
Average Rating
536 global ratings
87.0%
5.0%
3.0%
3.0%
2.0%
RC

Working with Whitehall training for the last two years of partnership has been a very successful experience – I have fast access to all the GCP course...

SM

I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...

Frequently Asked Questions

  • PV and Drug Safety Associates
  • Clinical Research Professionals
  • Regulatory Affairs Professionals
  • Quality and Compliance Teams
  • Life Sciences Graduates & Career Switchers

  • End-to-end PV knowledge across drugs and devices
  • Global regulatory compliance understanding
  • Practical, inspection-ready skills
  • Career-aligned learning for PV roles
  • Certificate of completion

On completion, learners will be equipped to support pharmacovigilance operations, audits, regulatory submissions, and safety risk management in global pharmaceutical and medical device environments.